Viewing Study NCT03850067


Ignite Creation Date: 2025-12-25 @ 12:43 AM
Ignite Modification Date: 2026-02-25 @ 9:39 PM
Study NCT ID: NCT03850067
Status: COMPLETED
Last Update Posted: 2024-08-26
First Post: 2019-02-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Safety, Tolerability and Preliminary Efficacy Evaluation of CC-90011 Given in Combination With Cisplatin and Etoposide in Subjects With First Line, Extensive Stage Small Cell Lung Cancer
Sponsor: Celgene
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Small Cell Lung Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Safety View
None CC-90011 View
None Extensive stage small cell lung cancer View